Soma
Soma (Soma Precision Health, Inc.) is a San Francisco neurotech startup building a consumer mental fitness tracker that uses noninvasive multimodal AI biomarkers, starting with voice (word choice, speech rhythm, pitch and volume), to surface insights on focus, cognitive load, mental fatigue and mood.
About
Soma (Soma Precision Health, Inc.) is a San Francisco neurotech startup building a consumer mental fitness tracker that uses noninvasive multimodal AI biomarkers, starting with voice (word choice, speech rhythm, pitch and volume), to surface insights on focus, cognitive load, mental fatigue and mood. It targets self-optimizers who already track physical biomarkers. The product is in private beta; the company also runs the Clarity by Soma newsletter and Brain Workout community events in San Francisco.
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Soma
Soma (Soma Precision Health, Inc.) is a San Francisco neurotech startup building a consumer mental fitness tracker that uses noninvasive multimodal AI biomarkers, starting with voice (word choice, speech rhythm, pitch and volume), to surface insights on focus, cognitive load, mental fatigue and mood. It targets self-optimizers who already track physical biomarkers. The product is in private beta; the company also runs the Clarity by Soma newsletter and Brain Workout community events in San Francisco.
—
United States
BusinessLatest roundTotal raisedDate- Ellipsis Health
Voice AI care managers that follow up with patients and flag emotional or health risks
Series A · $45M · 2025-06
$45M - LANGaware
AI technology for predicting and monitoring cognitive and mental health conditions
Undisclosed · $2M · 2023-10
$2M - Hi Rasmus
ABA (applied behavior analysis) clinical technology platform for behavioral health providers, covering clinical data collection, care workflows, scheduling and outcome reporting
Strategic · $50M · 2026-09
$50M
China
BusinessLatest roundTotal raisedDate- 镜象科技
Digital therapeutics for mental health
Series A · 2024-12
— - 心跃智能
Mental health AI SaaS provider
Seed · $1M · 2024-08
$1M - NeuShen Therapeutics
Novel drugs for CNS psychiatric and neurological disorders, with the NeuChime small-molecule discovery platform and NeuGem AAV gene therapy platform; lead programs include NS-136 (M4 positive allosteric modulator) and NS-041 (KCNQ2/3 activator)
Series B · 2026-09
—
Europe
BusinessLatest roundTotal raisedDate- Unmind
Enterprise mental health and AI agent platform
Undisclosed · $35M · 2025-08
$35M - Kyan Health
Platform providing personalized mental health and well-being support for employees and their families.
Undisclosed · $13M · 2024-11
$13M - Clare&me
AI mental health assistant offering 24/7 support via phone and WhatsApp messages
Undisclosed · $4M · 2024-08
$4M
Other / unspecified
BusinessLatest roundTotal raisedDate- Mentaily
AI diagnostic tools that support mental health professionals with early detection and personalized assessment
Seed · $3M · 2025-05
$3M - Body & Crown
Culturally sensitive AI emotional wellness products for women, centered on the AI companion app Crownie
— - Hemispheric
AI analysis of non-invasive brain activity data to aid psychiatric diagnosis
2026-07
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 22 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.